Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1

J Neurosci. 2012 Oct 3;32(40):13945-55. doi: 10.1523/JNEUROSCI.0704-12.2012.

Abstract

After hypoxia, a critical adverse outcome is the inability to create new memories. How anterograde amnesia develops or resolves remains elusive, but a link to brain-based IL-1 is suggested due to the vital role of IL-1 in both learning and brain injury. We examined memory formation in mice exposed to acute hypoxia. After reoxygenation, memory recall recovered faster than memory formation, impacting novel object recognition and cued fear conditioning but not spatially cued Y-maze performance. The ability of mice to form new memories after hypoxia/reoxygenation was accelerated in IL-1 receptor 1 knockout (IL-1R1 KO) mice, in mice receiving IL-1 receptor antagonist (IL-1RA), and in mice given the caspase 1 inhibitor Ac-YVAD-CMK. Mechanistically, hypoxia/reoxygenation more than doubled caspase 1 activity in the brain, which was localized to the amygdala compared to the hippocampus. This reoxygenation-dependent activation of caspase 1 was prevented by broad-spectrum adenosine receptor (AR) antagonism with caffeine and by targeted A1/A2A AR antagonism with 8-cyclopentyl-1,3-dipropylxanthine plus 3,7-dimethyl-1-propargylxanthine. Additionally, perfusion of adenosine activated caspase 1 in the brain, while caffeine blocked this action by adenosine. Finally, resolution of anterograde amnesia was improved by both caffeine and by targeted A1/A2A AR antagonism. These findings indicate that amygdala-based anterograde amnesia after hypoxia/reoxygenation is sustained by IL-1β generated through adenosine-dependent activation of caspase 1 after reoxygenation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine / pharmacology
  • Adenosine / physiology*
  • Amino Acid Chloromethyl Ketones / pharmacology
  • Amnesia, Anterograde / enzymology*
  • Amnesia, Anterograde / etiology
  • Amnesia, Anterograde / physiopathology
  • Amygdala / drug effects
  • Amygdala / enzymology
  • Amygdala / physiology*
  • Animals
  • Caffeine / pharmacology
  • Caspase 1 / drug effects
  • Caspase 1 / physiology*
  • Caspase Inhibitors / pharmacology
  • Conditioning, Classical / drug effects
  • Conditioning, Classical / physiology
  • Cues
  • Enzyme Activation
  • Fear / drug effects
  • Fear / physiology
  • Hypoxia, Brain / complications*
  • Hypoxia, Brain / physiopathology
  • Interleukin 1 Receptor Antagonist Protein / pharmacology
  • MAP Kinase Signaling System
  • Male
  • Maze Learning / drug effects
  • Maze Learning / physiology
  • Mental Recall
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oxygen / metabolism
  • Oxygen / pharmacology
  • Receptors, Interleukin-1 Type I / deficiency
  • Receptors, Purinergic P1 / physiology
  • Recognition, Psychology / drug effects
  • Recognition, Psychology / physiology
  • Theobromine / analogs & derivatives
  • Theobromine / pharmacology
  • Xanthines / pharmacology

Substances

  • Amino Acid Chloromethyl Ketones
  • Caspase Inhibitors
  • Interleukin 1 Receptor Antagonist Protein
  • N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone
  • Receptors, Interleukin-1 Type I
  • Receptors, Purinergic P1
  • Xanthines
  • Caffeine
  • 3,7-dimethyl-1-propargylxanthine
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Caspase 1
  • Adenosine
  • Theobromine
  • Oxygen